Login or Sign Up
Lupin Ltd. Know Your Stock
15:58 Sep 12
Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Lupin Ltd.
68/100 High Financial Strength
Quality44/100 Mid Valuation
Valuation53/100 Technically Neutral
TechnicalSWOT
Strength
16
Weakness
2
Opportunity
0
Threat
0
93.33K
Market Cap (Cr)
25.23
PE Ratio
5.43
Price to Book Ratio
67.14
RSI
14.45 %
Net Profit Margin
Rating Based on 8 Analysts
Buy
63%
Hold
38%
Sell
0%
Buy
Analyst Price Target
The average price target is 2326 with a high estimate of 2626 and low estimate of 1950
Current 2043.40
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
